Oxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies
- 19 June 2012
- journal article
- review article
- Published by Taylor & Francis Ltd in Annals of Medicine
- Vol. 44 (sup1), S2-S16
- https://doi.org/10.3109/07853890.2011.653393
Abstract
Reactive oxygen species (ROS) are signaling molecules that influence many physiological processes. Increased ROS bioavailability and altered redox signaling (oxidative stress) have been implicated in chronic diseases including hypertension. Although oxidative stress may not be the sole cause of hypertension, it amplifies blood pressure elevation in the presence of other prohypertensive factors (salt, renin-angiotensin system, sympathetic hyperactivity). A major source for cardiovascular ROS is a family of non-phagocytic NADPH oxidases (Nox1, Nox2, Nox4, Nox5). Other sources of ROS involve mitochondrial electron transport enzymes, xanthine oxidase, and uncoupled nitric oxide synthase. Although evidence from experimental and animal studies supports a role for oxidative stress in the pathogenesis of hypertension, there is still no convincing proof that oxidative stress is a cause of human hypertension. However, what is clear is that oxidative stress is important in the molecular mechanisms associated with cardiovascular and renal injury in hypertension and that hypertension itself can contribute to oxidative stress. The present review addresses the putative function of ROS in the pathogenesis of hypertension and focuses on the role of Noxs in ROS generation in vessels and the kidney. Implications of oxidative stress in human hypertension are discussed, and clinical uncertainties are highlighted.This publication has 100 references indexed in Scilit:
- Direct interaction between Tks proteins and the N-terminal proline-rich region (PRR) of NoxA1 mediates Nox1-dependent ROS generationEuropean Journal of Cell Biology, 2011
- Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trialThe Lancet, 2010
- Role of the adaptive immune system in hypertensionCurrent Opinion in Pharmacology, 2010
- Inhibition of NADPH Oxidase is Neuroprotective after Ischemia—ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2009
- Low-sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humansJournal of Human Hypertension, 2009
- Calcium-Dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase Contributes to Vascular Oxidative Stress in Human Coronary Artery DiseaseJournal of the American College of Cardiology, 2008
- Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCɛ signaling axis in pulmonary artery smooth muscle cellsFree Radical Biology & Medicine, 2008
- Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cellsFree Radical Biology & Medicine, 2008
- Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertensionNature Clinical Practice Nephrology, 2006
- Reactive oxygen species in vascular biology: implications in hypertensionHistochemistry and Cell Biology, 2004